These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8826571)

  • 21. Antileukotriene therapy for asthma.
    Larsen JS; Jackson SK
    Am J Health Syst Pharm; 1996 Dec; 53(23):2821-30; quiz 2877-8. PubMed ID: 8957342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis.
    Malo PE; Bell RL; Shaughnessy TK; Summers JB; Brooks DW; Carter GW
    Pulm Pharmacol; 1994 Apr; 7(2):73-9. PubMed ID: 8081074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zileuton use and phenotypic features in asthma.
    Thalanayar Muthukrishnan P; Nouraie M; Parikh A; Holguin F
    Pulm Pharmacol Ther; 2020 Feb; 60():101872. PubMed ID: 31841698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [5-lipoxygenase inhibitors in asthma therapy].
    Tanaka R
    Nihon Rinsho; 1996 Nov; 54(11):3040-4. PubMed ID: 8950951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
    Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
    Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors.
    Drazen J
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S233-7; discussion S247-8. PubMed ID: 9647605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats.
    Namovic MT; Walsh RE; Goodfellow C; Harris RR; Carter GW; Bell RL
    Eur J Pharmacol; 1996 Nov; 315(1):81-8. PubMed ID: 8960868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.
    Rubin P; Dubé L; Braeckman R; Swanson L; Hansen R; Albert D; Carter G
    Agents Actions Suppl; 1991; 35():103-16. PubMed ID: 1781415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects.
    Fischer AR; McFadden CA; Frantz R; Awni WM; Cohn J; Drazen JM; Israel E
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1203-7. PubMed ID: 7551371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Zileuton-Hydroxycinnamic Acid Hybrids: Synthesis and Structure-Activity Relationship towards 5-Lipoxygenase Inhibition.
    Chiasson AI; Robichaud S; Ndongou Moutombi FJ; Hébert MPA; Mbarik M; Surette ME; Touaibia M
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
    Chen X; Wang S; Wu N; Sood S; Wang P; Jin Z; Beer DG; Giordano TJ; Lin Y; Shih WC; Lubet RA; Yang CS
    Clin Cancer Res; 2004 Oct; 10(19):6703-9. PubMed ID: 15475461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings.
    Kane GC; Pollice M; Kim CJ; Cohn J; Dworski RT; Murray JJ; Sheller JR; Fish JE; Peters SP
    J Allergy Clin Immunol; 1996 Feb; 97(2):646-54. PubMed ID: 8621850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
    Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
    Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
    Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zileuton, a 5-lipoxygenase inhibitor, increases production of thromboxane A2 and platelet aggregation in patients with asthma.
    Wu X; Dev A; Leong AB
    Am J Hematol; 2003 Sep; 74(1):23-5. PubMed ID: 12949886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and efficacy of zileuton controlled-release tablets as adjunctive therapy to usual care in the treatment of moderate persistent asthma: a 6-month randomized controlled study.
    Wenzel S; Busse W; Calhoun W; Panettieri R; Peters-Golden M; Dube L; Walton-Bowen K; Russell H; Harris J
    J Asthma; 2007 May; 44(4):305-10. PubMed ID: 17530530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New approaches to anti-inflammatory therapy for asthma.
    Wenzel SE
    Am J Med; 1998 Mar; 104(3):287-300. PubMed ID: 9552092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zileuton.
    McGill KA; Busse WW
    Lancet; 1996 Aug; 348(9026):519-24. PubMed ID: 8757156
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers.
    Awni WM; Braeckman RA; Cavanaugh JH; Locke CS; Linnen PJ; Granneman GR; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():112-24. PubMed ID: 8620667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of 5-lipoxygenase inhibition on Ascaris antigen (Ag)-induced responses in atopic monkeys.
    Turner CR; Smith WB; Andresen CJ; Eggler JF; Watson JW
    Inflamm Res; 1996 Jan; 45(1):42-9. PubMed ID: 8821778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.